95-20339. Manufacturer of Controlled Substances; Notice of Application

[Federal Register Volume 60, Number 159 (Thursday, August 17, 1995)]
[Notices]
[Page 42905]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-20339]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 14, 1995, Noramco of 
Delaware, Inc., Division of McNeilab, Inc., 500 Old Swedes Landing 
Road, Wilmington, Delaware 19801, made application to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Codeine (9050)................................................  II      
Oxycodone (9143)..............................................  II      
Hydrocodone (9193)............................................  II      
Morphine (9300)...............................................  II      
Thebaine (9333)...............................................  II      
Alfentanil (9737).............................................  II      
Fentanyl (9801)...............................................  II      
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers as bulk product.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments, or objections may be addressed to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, United States Department of Justice, Washington, D.C. 
20537, Attention: DEA Federal Register Representative (CCR), and must 
be filed no later than October 16, 1995.

    Dated: August 10, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-20339 Filed 8-16-95; 8:45 am]
BILLING CODE 4410-09-M